Social Data for Pharmas: High-Volume, High-Value and Definitely Not Just for Marketers [Infographic]
The continuing and dramatic growth of social media data streams has put a new tool in the hands of pharmaceutical companies – and not just marketers.
Pharmacovigilance and drug safety teams are starting to leverage the power of social media to more effectively conduct post-marketing surveillance. R&D and innovation groups are turning to social media for new insights into unmet needs and to identify candidates for drug repositioning and repurposing.
Check out our new infographic – Social Data for Pharmas: High-Volume, High-Value and Definitely Not Just for Marketers – for a perspective on the “state of social media in pharma.”